New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareSemaglutide vs SNAP-8

Semaglutide vs SNAP-8

Side-by-side comparison of key properties, dosing, and research.

GLP-1 / Weight Loss Agonists
Semaglutide
Skin & Cosmetic
SNAP-8
Summary
Semaglutide is an FDA-approved GLP-1 receptor agonist originally developed for type 2 diabetes that has proven remarkably effective for weight loss. Clinical trials show average 15–20% body weight reduction. It is marketed as Ozempic (diabetes) and Wegovy (weight management).
SNAP-8 is a synthetic octapeptide cosmetic ingredient that reduces the depth of expression lines and wrinkles by competitively inhibiting the SNARE complex involved in acetylcholine release at neuromuscular junctions, providing a topical 'Botox-like' effect.
Half-Life
~7 days
N/A — topical application; local effect duration depends on formulation
Admin Route
SubQ, Oral
Topical
Research
Typical Dose
0.25 mg → 0.5 mg → 1 mg → 1.7 mg → 2.4 mg
3–10% concentration in formulation
Frequency
Once weekly, subcutaneous
1–2x daily
Key Benefits
  • Average 15–20% body weight reduction in clinical trials (STEP trials)
  • Significant reduction in appetite and food cravings
  • Improvement in blood sugar control and insulin sensitivity
  • Reduces cardiovascular risk (SELECT trial: 20% reduction in MACE)
  • May reduce risk of kidney disease
  • Improves metabolic markers (cholesterol, blood pressure)
  • FDA-approved — extensively studied with robust safety data
  • Weekly dosing convenience
  • Reduces depth of dynamic expression wrinkles
  • Smooths forehead lines, crow's feet, glabellar lines
  • Non-invasive topical Botox alternative
  • Can be incorporated into serums, creams, eye contour products
  • Reduces muscle contraction without paralysis
  • Improves skin texture and firmness over time
  • Complements other anti-aging peptides (Argireline, Matrixyl)
Side Effects
  • Nausea (most common, especially during titration)
  • Vomiting
  • Diarrhea or constipation
  • Abdominal discomfort
  • +4 more
  • Generally excellent tolerability
  • Rare: mild redness in sensitive individuals
  • Not suitable for injection (topical use only)
Stacks With